Richard John Wallace's Net Worth

-$147 Thousand

Estimate Recalculated Sep 8, 2024 07:34PM EST

Who is Richard John Wallace?

Richard John Wallace does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., GNC ACQUISITION HOLDINGS INC., AVIGEN INC \DE, and CLINICAL DATA INC.

SEC CIK

Richard John Wallace's CIK is 0001357149

Past Insider Trading and Trends

2013 was Richard John Wallace's most active year for acquiring shares with 4 total transactions. Richard John Wallace's most active month to acquire stocks was the month of October. 2024 was Richard John Wallace's most active year for disposing of shares, totalling 13 transactions. Richard John Wallace's most active month to dispose stocks was the month of January. 2021 saw Richard John Wallace paying a total of $297,880.00 for 59,000 shares, this is the most they've acquired in one year. In 2011 Richard John Wallace cashed out on 60,000 shares for a total of $741,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ImmunoGen, Inc. (IMGN) No price found

Investor

Richard John Wallace used to own units in Common Stock but no longer holds any shares there. From 2021 to 2024 Richard John Wallace acquired a total of 10,000 shares in ImmunoGen, Inc. at a cost of $147,000.00, Richard also disposed a total of 10,000 shares of ImmunoGen, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-10.00K
—
—
0
Feb 12
Form 4
∞
10K
$14.70
$147,000.00
10K
Nov 7
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Nov 10
Form 4
—
0
—
—
0
Nov 11
Form 4
—
0
—
—
0
Nov 12
Form 4
—
0
—
—
0
Nov 13
Form 4
—
0
—
—
0
Nov 8
Form 4
—
0
—
—
0
Nov 16 - Nov 17
Form 4
—
0
—
—
0
Nov 11
Form 4
—
0
—
—
0
Nov 12
Form 4
—
0
—
—
0
Nov 13
Form 3
—
0
—
—
0
No matching records found

GNC ACQUISITION HOLDINGS INC. No price found

Investor

Richard John Wallace owns 7,118 units of Class A common stock, par value $0.001 per share and 60,363 units of Common Stock.acquired a total of 60,363 shares in GNC ACQUISITION HOLDINGS INC..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+109.93%
31.61K
—
—
60.36K
May 21
Form 4
+105.55%
14.77K
—
—
28.75K
May 22
Form 4
+46.62%
4.45K
—
—
13.99K
May 23
Form 4
+34.04%
2.42K
—
—
9.54K
May 21
Form 4
+57.58%
2.6K
—
—
7.12K
May 21
Form 4
+85.43%
2.08K
—
—
4.52K
May 22
Form 4
+57.67%
891
—
—
2.44K
Feb 20
Form 4
∞
1.54K
—
—
1.54K
Apr 30
Form 3
—
0
—
—
0
No matching records found

AVIGEN INC \DE No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Mar 20
Form 3
—
0
—
—
0
No matching records found

CLINICAL DATA INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 13
Form 4
—
0
—
—
0
Sep 16
Form 4
—
0
—
—
0
Sep 17
Form 4
—
0
—
—
0
Sep 23
Form 4
—
0
—
—
0
Sep 25
Form 3
—
0
—
—
0
No matching records found